via TAU
Technique combines ultrasound application and tumor-targeted microbubbles that attach to cancer cells and explode
An international research team led by Dr. Tali Ilovitsh of the Biomedical Engineering Department at TAU developed a noninvasive technology platform for gene delivery into breast cancer cells. The technique combines ultrasound with tumor-targeted microbubbles. Once the ultrasound is activated, the microbubbles explode like smart and targeted warheads, creating holes in cancer cells’ membranes, enabling gene delivery. Conducted over two years, the research was published on June 9 in the journal Proceedings of the National Academy of Sciences (PNAS).
Dr. Ilovitsh developed this breakthrough technology during her post-doctorate research at the lab of Prof. Katherine Ferrara at Stanford University. The technique utilizes low frequency ultrasound (250 kHz) to detonate microscopic tumor-targeted bubbles. In vivo, cell destruction reached 80% of tumor cells.
“Microbubbles are microscopic bubbles filled with gas, with a diameter as small as one tenth of a blood vessel,” Dr. Ilovitsh explains. “At certain frequencies and pressures, sound waves cause the microbubbles to act like balloons: they expand and contract periodically. This process increases the transfer of substances from the blood vessels into the surrounding tissue. We discovered that using lower frequencies than those applied previously, microbubbles can significantly expand, until they explode violently. We realized that this discovery could be used as a platform for cancer treatment and started to inject microbubbles into tumors directly.”
Dr. Ilovitsh and the rest of the team used tumor-targeted microbubbles that were attached to tumor cells’ membranes at the moment of the explosion, and injected them directly into tumors in a mouse model. “About 80% of tumor cells were destroyed in the explosion, which was positive on its own,” says Dr. Ilovitsh. “The targeted treatment, which is safe and cost-effective, was able to destroy most of the tumor. However, it is not enough. In order to prevent the remaining cancer cells to spread, we needed to destroy all of the tumor cells. That is why we injected an immunotherapy gene alongside the microbubbles, which acts as a Trojan horse, and signaled the immune system to attack the cancer cell.”
On its own, the gene cannot enter into the cancer cells. However, this gene aimed to enhance the immune system was co-injected together with the microbubbles. Membrane pores were formed in the remaining 20% of the cancer cells that survived the initial explosion, allowing the entry of the gene into the cells. This triggered an immune response that destroyed the cancer cell.
“The majority of cancer cells were destroyed by the explosion, and the remaining cells consumed the immunotherapy gene through the holes that were created in their membranes,” Dr. Ilovitsh explains. “The gene caused the cells to produce a substance that triggered the immune system to attack the cancer cell. In fact, our mice had tumors on both sides of their bodies. Despite the fact that we conducted the treatment only on one side, the immune system attacked the distant side as well.”
Dr. Ilovitsh says that in the future she intends to attempt using this technology as a noninvasive treatment for brain-related diseases such as brain tumors and other neurodegenerative conditions such as Alzheimer’s and Parkinson’s diseases. “The blood-brain barrier does not allow for medications to penetrate through, but microbubbles can temporary open the barrier, enabling the arrival of the treatment to the target area without the need for an invasive surgical intervention.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Tumor-targeted microbubbles
- Scientists identify and show how to target a key tumor defense against immune attack
A new study has discovered how a lipid molecule found at high levels within tumors undermines the anti-cancer immune response and compromises a recently approved immunotherapy known as adoptive cell ...
- Ultrasound Devices Market is Set to Surpass Valuation of USD 11,229.9 Million By 2032: Astute Analytica
The global ultrasound devices market surges, driven by rising chronic diseases, technological advancements in portability and imaging, and an aging population demanding accessible diagnostics. Growth ...
- Cancer Breakthrough Found to Boost Immune Cells Without Harmful Side-Effects By Directing Protein Cytokines
A new way to safely boost immune cells to fight cancer—avoiding harmful side-effects such as hair loss—has been developed.
- Targeted therapies outperform hundreds of other drugs in 'priming' lung cancer cells for destruction
Through millions of years of evolutionary refinement, the human body has developed a sophisticated surveillance mechanism—the immune system. This intricate network is constantly scanning the body for ...
- Tumor Microbiome May Help Predict Efficacy of ICIs in Metastatic Cancer
Analyzing the tumor microbiome may aid prognostication in patients receiving immune checkpoint inhibitor therapy for metastatic cancer.
Go deeper with Google Headlines on:
Tumor-targeted microbubbles
[google_news title=”” keyword=”tumor-targeted microbubbles” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Ultrasound with tumor-targeted microbubbles
- Targeted Drugs in Combination With Radiotherapy for the Treatment of Solid Tumors
as many of the targeted compounds display synergistic effects with RT, at least under experimental conditions, and many have been found to be of value in preclinical animal tumor models.
- Focused therapy cuts side effects in treating prostate cancer
Defense Secretary Lloyd Austin's medical issues last December put the spotlight on fighting prostate cancer while reducing ... high-intensity focused ultrasound or HIFU - is becoming a bigger ...
- Understanding Metastatic Breast Cancer in the Lungs
Chemotherapy is also used with HER2-targeted therapies for HER2-positive breast cancer. If you’ve previously had chemotherapy, your cancer may have become resistant to those drugs. Trying other ...
- Targeted Therapy, Treatment Disparity Featured at Cancer Meeting
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapy, cancer genomics, eliminating treatment disparities and other cancer research topics at this year’s ...
- Advancing high-resolution ultrasound imaging with deep learning
Researchers at the Beckman Institute for Advanced Science and Technology have developed a new technique to make ultrasound localization microscopy, an emerging diagnostic tool used for high-resolution ...
Go deeper with Google Headlines on:
Ultrasound with tumor-targeted microbubbles
[google_news title=”” keyword=”ultrasound with tumor-targeted microbubbles” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]